Since 2011, Yale has been offering an innovative way to treat breast cancer: hypofractionated breast radiation. This treatment involves three to four weeks of radiation rather than the traditional five to six. This approach has been proven to be just as effective as the standard six weeks of radiation with fewer side effects.
Hypofractionated breast radiation has been identified by the American Society for Radiation Oncology's (ASTRO) Choosing Wisely Campaign as an intervention that all physicians should consider strongly for the breast cancer patients. This treatment has been proven to be highly effective for women after lumpectomy, when lymph node areas do not need to be targeted. At Yale Medicine, we offer this treatment to women who have undergone chemotherapy as well.
Our team is trained in all three methods of partial breast irradiation including external beam conformal therapy, interstitial brachytherapy and MammoSite.